News

Aspirin is inexpensive and readily available in almost every country. According to a meta-analysis, taking a daily low dose (75 or 81 mg/day) of aspirin was associated with a 20% reduction in deaths from cancer and in deaths from all causes.

Technology Networks caught up with the researchers behind an eight-week clinical trial testing the effects of Bikram yoga on depressive symptoms.

Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies.

A class of small molecules has been shown to help mice regain brain function after a stroke, opening doors to new stroke recovery therapies.

Researchers at the Dana-Farber Cancer Institute have developed a promising new drug candidate, EAI-432, to treat drug-resistant non-small cell lung cancers.

According to research, inhibiting the galectin 1 protein, which is often over-expressed in hepatocellular carcinoma (HCC) using gene therapy can shrink HCC and increase the number of killer T cells inside tumors in mice.

A "super power" used by plants to deter predators has inspired a new tool that may help researchers develop new pharmaceuticals in a cleaner, greener, less expensive way.

The largest review of papers on cancers that have metastasized to the brain has shown that existing licenced drugs could be trialed as a treatment.

A 20-year study has found no evidence to suggest that cannabis use reduces illicit opioid use, indicating it may not be an effective treatment or management option for those with opioid use disorder.

A new study reveals for the first time the steps through which human immunodeficiency virus (HIV) binds to the receptors on the membranes of T cells.